Click Here for Surgeons · 12-minute read

Own your panel. Capture what you've already earned.

This is the audience-tailored version of Click Here — the book about AI ending the digital economy and beginning the human one. Written for the orthopedic surgeon who is tired of fighting denials one at a time, and would rather use AI to surface the appropriate revenue that has already been earned but is leaking through the cracks of the practice management system.

The full canonical book is at /book. This page is the twelve-minute surgeon's-side distillation: the WISeR collapse, what the surgeon owns versus what the system extracts, and the cooperative architecture for capturing what is yours.

▸ ~12 minutes · adapted for orthopedic surgeons · pairs with Click Here for Families + Click Here for Builders

01The question every surgeon eventually asks

You felt it on the drive home from clinic, sometime in the last two years. The denial letter from a payer, written by an algorithm you cannot interrogate, telling you that the procedure you had just spent fifteen minutes explaining to a frightened patient was not authorized — for reasons that had nothing to do with the clinical question and everything to do with the payer's quarterly target. The patient called the office the next morning and asked, in tears, why you had recommended a surgery the insurance would not cover. You did not have a good answer that would not require you to publicly say what you actually thought about the payer.

The question every surgeon eventually asks is some version of the same question: I went to medical school for fifteen years of training so that I could spend my Wednesday afternoons writing appeal letters to algorithms?

The structural answer to that question is the subject of this page. It has three pieces — and they have all become sharper in the past sixty days, since CMS's WISeR pilot lost its funding.

02The WISeR collapse — what just happened

On June 9, 2026, the House Appropriations Committee adopted by voice vote — bipartisan, in a Republican-led committee — an amendment to the 2027 spending bill blocking any CMS funds from going to WISeR or similar AI-driven prior-authorization models. WISeR was CMS's pilot of AI-powered utilization review, rolled out to providers in Arizona, Washington, New Jersey, Texas, Ohio, and Oklahoma earlier this year. Knee arthroscopy for arthritis — a procedure with limited evidence of benefit in most patients — was one of WISeR's targets.

The political read is unambiguous: AI-driven prior-authorization-for-denial is now structurally radioactive in U.S. healthcare policy. The article that broke the story named the load-bearing problem cleanly:

"Third parties providing review services in WISeR were effectively compensated for denials."

That is the extraction-machinery dynamic from Chapter 7 of this book, applied to utilization review. The reviewer's revenue grows when they deny. No regulation can fix this; the corporate form exists to widen the spread. The same critique the book makes of platform extraction applies, dollar for dollar, to insurance-company-and-AI-vendor-paid prior authorization.

What this means for the surgeon, structurally: the AI denial machine just lost its political cover. The political-economic moment is shifting from "AI to deny appropriate care for payer profit" to "AI to surface the appropriate care, attested by a physician of record." The cooperative form is what's structurally left after WISeR. So is the surgeon-side application of it.

03What the system extracts — what the surgeon owns

The honest accounting of the orthopedic surgeon's economic life in 2026 has three columns:

The platform trap closing on builders (Chapter 7 of the book) is closing on surgeons too. The expert-network platforms, the AI-coded prior-auth services, the value-based-care arbitrators, the consolidating practice-management vendors — each one stakes a claim on the trust you built across a career and prices it back to you at a discount, while pricing the buyer at a premium they call "platform fee."

The fix has the same shape on the surgeon side as on the family-caregiver side and the builder side: own the substrate of your own work in a form the platforms can't extract. For a surgeon, that means three specific things — owning your panel, capturing what you've already earned, and standing in a cooperative form where the surplus from your work returns to you.

04Own your panel

The single most undervalued asset in the orthopedic surgeon's economic life is the panel itself — the cohort of patients whose musculoskeletal histories you know, whose surgical outcomes you have tracked, whose referral relationships extend through the families and the workplaces they came from. The hospital system that employs you treats this panel as the hospital's asset. The EHR vendor treats it as a derivative they can sell. The payer treats it as a denominator for quality calculations they performed without consulting you.

It is none of those. It is the longitudinal clinical experience of a single physician across a single body of patients, and it has structural value that compounds every year you keep it. The cooperative architecture begins here: your panel is YOUR panel, stored in YOUR own context layer, owned by you and only by you, with the structural assurance that no platform can ever extract it from you when you leave.

What this looks like in practice via SurgeonValue:

05Capture what you've already earned

Wonder Bill is the load-bearing piece of SurgeonValue for the surgeon-economic argument. Most orthopedic practices leave between $200,000 and $1.2 million per surgeon per year of appropriate, earned, clinically-defensible revenue on the table — not from fraud, not from over-coding, but from systematic gaps: missed RTM/CCM billing, missed prior-auth submission windows, missed appropriate code modifiers, missed care-coordination billing, missed transitional-care-management codes after discharge, and so on.

The current standard response in the industry is to hire a billing-and-coding consultant who reviews charts after the fact and bills for catch-up. The consultant takes 15-25% of recovered revenue. The surgeon does most of the cleanup work to make the consultant's audits hold up. The net is meaningful but not transformative.

SurgeonValue runs a different play. Apple Intelligence on the surgeon's iPhone reads the encounter, surfaces the missed codes BEFORE the bill is submitted, drafts the appropriate documentation in the surgeon's voice, and submits clean. The on-device-first architecture means the patient data never leaves the surgeon's device for the routine read — and the surgeon's appropriate documentation actually improves the patient's chart for the next visit.

The math, conservatively: $200,000–$1.2 million/year per surgeon of appropriate revenue capture, with no per-bill take rate going to a consultant, and the surgeon's documentation improving by side effect. The cooperative's platform fee is small and capped; surplus returns to surgeons via patronage equity.

06The cooperative form, for surgeons specifically

Stand in a cooperative where the surplus from your professional work returns to YOU as patronage equity, not to outside shareholders. The cooperative form (Limited Cooperative Association, Colorado LCA, Colorado C.R.S. § 7-58) protects you in five specific ways:

What this means concretely for the WISeR-collapse moment: the cooperative attesting-reviewer model is the structural answer the article's closing question was asking for. A reviewer who is a fellow cooperative member of the patient, whose compensation is for quality of attestation rather than volume of denials, whose decisions are recorded immutably on a HashCare Merkle log — that is the model that survives the political collapse of WISeR-style AI denial. SurgeonValue is the surgeon's-side instantiation. ClinicalSwipe is the marketplace where physicians do the attesting. Altru.care is the legal substrate.

07What's real today, honestly

SurgeonValue today: the Wonder Bill missed-code surfacing for orthopedic surgeons, the Voice PROM completion flow, the EMR-integrated encounter ingestion for the major systems (Epic, Cerner, athena, eClinicalWorks, ModMed), and the panel-intelligence dashboard on the web. The first surgeon pilot is in active design-partner engagement at a university-affiliated orthopedic practice.

What unlocks at scale: the iOS app shipped at iOS 27 GA (September 14, 2026) with the on-device Apple Intelligence integration, the multimodal photo-to-data flow for hospital bills and lab values, the federation rails between SurgeonValue practices and the broader cooperative network, and the Provident Account distribution to surgeon members from year-end surplus.

The cooperative form is durable. The plumbing is built. The Mutual clears at member counts the founding circle is moving toward — not on day one. The honest scope is on /mutual and the political moment is documented at /the-gap.

▸ Click here

Try SurgeonValue.

The orthopedic surgeon's AI front office. Wonder Bill to capture appropriate revenue you've already earned. Voice PROM completion. Panel-level intelligence on your phone. Founding share at $100 for cooperative standing — refundable on exit, vote on governance, founding rate locked in for life.

▸ This is the audience-tailored version of Click Here. The canonical book — 13 chapters, polished prose — is at co-op.care/book. The WISeR-collapse sourced analysis is at co-op.care/the-gap. The family-caregiver version of this mini-book is at co-op.care/families. The builder version is at co-op.care/builders.

The cooperative was always one philosophy with many doors. This was the surgeon's door. WISeR collapsed; SurgeonValue is what's left.